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Abstract
Background: The human placenta is a rapidly developing organ that undergoes structural and functional changes
throughout the pregnancy. Our objectives were to investigate the differences in global gene expression profile, the
expression of imprinted genes and the effect of smoking in first and third trimester normal human placentas.
Materials and Methods: Placental samples were collected from 21 women with uncomplicated pregnancies delivered at
term and 16 healthy women undergoing termination of pregnancy at 9–12 weeks gestation. Placental gene expression
profile was evaluated by Human Genome Survey Microarray v.2.0 (Applied Biosystems) and real-time polymerase chain
reaction.
Results: Almost 25% of the genes spotted on the array (n=7519) were differentially expressed between first and third
trimester placentas. Genes regulating biological processes involved in cell proliferation, cell differentiation and angiogenesis
were up-regulated in the first trimester; whereas cell surface receptor mediated signal transduction, G-protein mediated
signalling, ion transport, neuronal activities and chemosensory perception were up-regulated in the third trimester. Pathway
analysis showed that brain and placenta might share common developmental routes. Principal component analysis based
on the expression of 17 imprinted genes showed a clear separation of first and third trimester placentas, indicating that
epigenetic modifications occur throughout pregnancy. In smokers, a set of genes encoding oxidoreductases were
differentially expressed in both trimesters.
Conclusions: Differences in global gene expression profile between first and third trimester human placenta reflect
temporal changes in placental structure and function. Epigenetic rearrangements in the human placenta seem to occur
across gestation, indicating the importance of environmental influence in the developing feto-placental unit.
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Introduction
Molecular, histological and functional rearrangements of the
placenta are necessary throughout pregnancy in order to ensure
appropriate fetal development and maternal health. The gestation-
related regulation of placental development is probably driven by
genetic, fetal, maternal and environmental factors. However, the
molecular mechanisms behind this process are unknown [1]. As
gestation advances the needs of the fetus change and the placenta
adapts to these changes. Placental weight is related to fetal growth,
with progressive increase of the fetal-placental weight ratio from
1:2.9 at 24 weeks gestation to 1:6.8 at term [2].
The formation of the placenta is characterised by a rapidly
growing, undifferentiated trophoblast that acquires a villous and
an extravillous phenotype. The villous cytotrophoblast enters the
syncytial pathway, while the extravillous trophoblast invades the
maternal decidua. Both lineages differentiate in parallel in order
to establish the feto-maternal circulation. The total surface area
of the villi in the normal human placenta is linearly associated
with placental volume [3]. Morphological studies have demon-
strated a continuous evolution of the different chorionic villous
types during gestation [4]. The decrease in trophoblast
proliferation along with a relative increase in endothelial
proliferation causes a switch from branching to non-branching
angiogenesis in the third trimester. This results in the formation
of long and slender villous trees containing one or two poorly
branched capillary loops, which in turn, cause a decrease in feto-
placental vascular impedance [5]. These morphological changes
in villous tree development are reflected in the hemodynamic
changes observed in the feto-placental circulation. Indeed,
ultrasound assessment of the feto-placental circulation shows a
gradual increase in the fraction of the fetal cardiac output
distributed to the placenta in the second trimester [6] with slight
decrease towards term [7].
Intrauterine environment influences placental development.
There is a switch from histiotrophic nutrition in the first trimester
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33294to hemotrophic nutrition later in pregnancy [8]. Moreover, in utero
environment seems to play an important role not only for fetal
development, but also for health in adult life, through epigenetic
programming. The placenta is considered to be a major site of
epigenetic regulation from the pre-implantation period to delivery
[9].
The human placenta expresses more than 12000 genes [10],
including most of the currently known imprinted genes. We
hypothesized that molecular rearrangements and phenotypic
adaptations that are necessary for normal placental development
are reflected in its gene expression levels. The aims of this study
were to investigate differences in global gene expression profile,
the expression of imprinted genes in particular and the effect of
smoking in the first and third trimester placenta during normal
human pregnancy.
Results
The phenotype of the study population is shown in Table 1.
There were no differences regarding maternal age, gravidity and
parity among groups, but the percentage of women smoking
tobacco was higher in the first trimester group compared to the
third trimester.
We found 7519 genes to be differentially expressed between first
and third trimester placentas (Figure 1 and TableS1), representing
almost 25% of the genes spotted on the array. Principal
component analysis (PCA) showed a clear separation between
first and third trimester placentas (Figure 2). Panther analysis with
Bonferroni correction for multiple testing (p#0.01) showed several
biological processes (Figure 3a) and molecular pathways (Figure 3b)
to be differentially expressed between the groups. Among
differentially expressed genes, those involved in biological
processes such as nucleic acid metabolism, protein metabolism
and modification, mRNA transcription, cell cycle, cell structure
and motility were highly (p#0.001) up-regulated in the first
trimester placentas, whereas cell surface receptor mediated signal
transduction, G-protein mediated signalling, ion transport,
neuronal activities and chemosensory perception were up-
regulated in the third trimester. Pathway analysis indicated that
genes involved in angiogenesis, Huntington disease, Parkinson
disease, Ubiquitin proteasome, Ras and Notch signalling pathways
were differentially expressed between first and third trimesters. We
used Human Neurogenesis and Neural Stem Cell PCR Array to
test the hypothesis that brain and placenta might share common
developmental pathways. We found that twenty six out of the 84
genes (31%) represented on the PCR array that are known to be
involved in human neurogenesis were significantly (i.e $2 fold)
differentially expressed between first and third trimester placentas
(Figure S1). Of these 26 genes, 12 showed good correlation with
PCR, 9 genes had low expression levels in microarrays, 1 gene was
not differentially expressed between the groups in microarrays and
4 genes had opposite expression in microarrays compared to PCR
(Table S2).
We further investigated gene expression profiles of 50 known
imprinted human genes between first and third trimester
placentas. Many of these genes were not present on the array or
had very low intensity signals. However, PCA based on the
expression of 17 imprinted genes could clearly differentiate first
and third trimester placentas (Figure S2). We validated this result
by RT-PCR for 6 selected imprinted genes and found that insulin-
like growth factor 2 (IGF2) and Pleckstrin homology-like domain
family A member 2 (PHLDA2) were differentially expressed
between the groups (Table S3).
Table 1. Phenotype of the study population.
I trimester (n=16) III trimester (n=21) p-value
Maternal age (years) 28.1966.8 30.2464.8 0.3
Gravidity (n 6 standard error) 3.360.5 2.960.6 0.5
Parity n (n 6 standard error) 160.3 1.360.5 0.7
Smoking n (%) 9 (56) 3 (14) 0.01
Gestational age at sampling (days) 71.2682 7 5 68 0.00
Data are presented as mean 6 SD, n (%) or median (range). Differences between the groups were assessed using Student’s t-test for parametric and Chi-square test for
categorical variables.
doi:10.1371/journal.pone.0033294.t001
Figure 1. Venn diagram showing the number of differentially
expressed genes between the groups: smoking versus non-
smoking placentas at the first (a) and third (b) trimester of
pregnancy; and first versus third trimester placentas irrespec-
tive of smoking status(c). The areas of interception of the circles
(ab+abc) indicate 27 genes that were affected by smoking throughout
pregnancy.
doi:10.1371/journal.pone.0033294.g001
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expressed in the placentas of the women who smoked during
pregnancy compared to non-smokers, both in the first and third
trimesters of pregnancy (Figure 1). Four among the 27 genes that
were affected by smoking encode for oxidoreductases. More
specifically cyclooxygenase 2 and 5B (COX2, COX5B) and
cytochrome P450 (CYP) 2D1 and 22D7 isoforms (CYP2D1,
CYP2D7) were differentially expressed both in the first and third
trimester placentas from women smoking during pregnancy. We
validated this result by PCR on individual placental samples and
found that COX2 was up-regulated and COX5B was down-
regulated by smoking in both trimesters (Table S4).
Discussion
There is abundant literature regarding differential gene
expression profile between healthy and compromised placentas,
specially in the context of preeclampsia [11]. However, differences
in gene expression profile during normal development of the
human placenta are still not fully understood. Previously only one
microarray study has addressed this issue [12]. Our aim was to
find molecular pathways involved in gestation-related physiolog-
ical changes in placental structure and function. We found that
more than half of the genes that are expressed in the human
placenta -i.e. 7519 of 12000 genes expressed in placenta - change
their expression profile from the first to the third trimester of
pregnancy, which confirms that the placenta undergoes a
profound molecular rearrangement in order to adapt to the
changing demands of the fetus.
Genes related to biological processes such as nucleic acid
metabolism, protein metabolism and modification, mRNA
transcription, cell cycle, cell structure and motility were highly
expressed in the first trimester placentas indicating that the
placenta undergoes intense cell proliferation and differentiation
during this period. This observation is in accordance with the
findings of Mikheev et al [12] and is also supported by another
genomic study on human placenta [13]. Longitudinal studies on
gene expression in human placenta are lacking mainly due to
ethical constraints. However, a study in mice suggested that a
transition occurs at mid-gestation and different genes are
expressed by the same cellular populations without any major
morphological changes in the placenta [14]. Moreover, a human
microarray study of basal plate biopsy specimens of the maternal-
fetal interface showed dramatic changes between midgestation and
term [15]. This is in line with the pattern of fetal and placental
weight gain seen in human pregnancy. In early gestation the
weight of the placenta is higher and increases more rapidly than
the weight of the fetus, but the placental growth slows down later
in gestation while that of the fetus continues with an apparent
cross-over around mid-gestation.
Figure 2. Two-dimensional principal component analysis of the differentially expressed placental genes with best t-scores in the
main analysis. Each spot represents a placental sample: 16 first trimester placentas (black spots) and 21 third trimester placentas (red spots).
doi:10.1371/journal.pone.0033294.g002
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first and third trimester placentas showed angiogenesis to be highly
active in first trimester. Other molecular pathways that were up-
regulated in the first trimester placentas are involved in
neurodegenerative disorders, namely Huntington disease, Parkin-
son disease and Notch signalling pathway. Our results from the
Neurogenesis and Neural Stem Cell PCR Array showed an overall
good correlation between microarray and PCR (Table S2). This is
in accordance with Morey J. et al. [16] who found that genes
exhibiting at least 1.4 fold change and p-value of #0.0001 in
microarray analyses consistently yield significant correlations of at
least 0.80 for array and PCR data. Furthemore, our results
indicate that there might be common developmental pathways
between brain and placenta. Indeed stem cells derived from
human placenta can be differentiated into neural progenitors in
vitro [17]. Moreover, the placenta produces a wide range of
neurohormones [18] that might affect fetal brain development
[19]. In a previous study we found similar neurologic molecular
pathways to be up-regulated in placentas affected by preeclampsia
[20]. One can thus hypothesize that misregulation of these
molecular pathways in early pregnancy could result in early
pregnancy loss, preeclampsia or IUGR.
Imprinting is an important genetic phenomenon occurring in
mammals [21]. Many genes undergoing epigenetic modifications
are expressed and specifically imprinted in the human placenta
[22]. Placental imprinting seems to be a dynamic process
occurring throughout pregnancy [23]. Using whole genome
methylation data in first and third trimester placental tissue, a
methylation-induced down regulation has been demonstrated for a
set of tumour-associated genes, as part of normal placentation
[24]. We found that expression of imprinted genes occurs in a
temporal manner during normal human placental development.
We demonstrated that IGF2 and PHLDLA2 were differentially
expressed between first and third trimester placentas. Unfortu-
nately, we are not able to include allele-specific analysis of
heterozygous samples because we did not collect maternal and
paternal blood samples. However, according to Monk et al [25]
who assessed the imprinting status of placental-specific imprinted
genes using first and third trimester placental tissue with
corresponding maternal and –for the third trimester only- paternal
blood samples, the expression of these genes is largely biallelic
throughout pregnancy. It has been shown that epigenetic
modifications of these genes have direct effects on placental size
and morphology as well as placental transport capacity [26].
Environmental conditions can also alter the epigenetic status of the
placenta which in turn affects fetal growth and development [26].
Moreover, several studies have shown that epigenetic disturbances
can be associated with placenta-related disorders such as IUGR
and preeclampsia.
It is known that smoking has significant morphological and
functional effects on the placenta [27]. Several studies have
investigated the impact of maternal smoking on placental gene
expression at term [28,29]. These studies have indicated that
several genes encoding for xenobiotic-metabolising enzymes of the
CYP complex are up-regulated by smoking in a temporal manner.
Interestingly, fetal exposure to tobacco increases placental
CYP1A1 expression, through hypomethylation of its gene
transcription factor binding element [30]. Moreover, Mikheev et
al have indicated that the expression of several CYPs is regulated
in the normal palecnta of non smoking mothers depending on
gestational age, probably because these enzymes are also involved
in steroid metabolism [12]. Therefore we performed subgroup
analysis in placentas obtained from women who smoked in the first
(n=9/16, 56%) and third (n=3/21, 14%) trimester compared to
non smokers. Although there was an unbalanced proportion of
smokers between the groups, data analysis showed that 793
(ac+abc+bc in figure 1) of 7519 (9.5%) differentially expressed
genes were affected by smoking. This indicates that the effect of
smoking on global placental gene expression profile is limited
compared to the effect of placental maturation. Furthermore, we
found in microarrays that only 27 (ab+abc in figure 1) placental
genes were affected by smoking both in the first and third
Figure 3. Box plots of the biological processes (3a) and molecular pathways (3b) that were differentially expressed between first
and third trimester placentas. The x axis represents the number of genes involved in each process/pathway that were differentially expressed
between the groups.
doi:10.1371/journal.pone.0033294.g003
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these genes showed specific regulation of COX2 and COX5B by
smoking regardless of gestational age. Moreover, there is
epidemiologic evidence that maternal cigarette smoking during
pregnancy reduces the risk of developing preeclampsia in both
primiparous and multiparous women [31,32]. Interestingly, we
previously found several oxidoreductases to be differentially
expressed between preeclamptic and normal placentas (suppl
table 1 in reference 20). It seems therefore reasonable to assume
that the regulation of specific xenobiotic enzymes from early
pregnancy until term in smoking mothers might protect them
against preeclampsia.
In conclusion, we found profound differences in global gene
expression profile between first and third trimester human
placenta reflecting temporal changes in placental structure and
function. Epigenetic rearrangements in the human placenta seem
to occur across gestation, indicating the importance of environ-
mental influence in the developing feto-placental unit. Smoking
affects specific placental oxidoreductases throughout pregnancy.
Methods
Study population
We recruited 24 healthy women with uncomplicated pregnan-
cies that were delivered at term and 16 women undergoing
surgical termination of pregnancy for social reasons, between 9–12
weeks of gestation. All women were healthy, Caucasian and had
low risk pregnancies. Gestational age was assigned by abdominal
ultrasound at 18–20 weeks of gestation and by transvaginal
ultrasound before termination of pregnancy. All pregnant women
recruited to the study had a physical examination and ultraso-
nography #48 hours before delivery or termination of pregnancy.
The study was approved by the Regional Ethics Committee for
Medical Research - North Norway (REK-Nord 94/2004) and
informed written consent was obtained from all participants.
Placental sample collection and conservation
Third trimester placental samples were obtained immediately
after delivery. Chorionic tissue was dissected from a standardized
location (approximately 2 cm beside the umbilical cord insertion,
from the middle layer of placenta midway between maternal and
fetal surfaces). Placental samples were collected from macroscop-
ically normal areas excluding sites of infarction, haemorrhage and
fibrin deposition. Chorionic tissue was obtained immediately after
termination of pregnancy from first trimester placentas and was
separated from decidua using light microscopy. The collected
specimen was transferred to a Petri dish and washed thoroughly
with physiological saline to remove any contamination with
maternal blood and amniotic fluid. Each tissue sample was
transferred to tubes containing 1.5 ml RNAlater solution (RNA
stabilization reagent, Qiagen GmbH, Germany), and stored at
270uC until RNA isolation, microarray experiment and RT-PCR
was performed.
RNA isolation and quality/quantity control
Disruption and homogenization of tissue specimens were
performed in lysis buffer using the MagNa Lyser Instrument
(Roche Applied Science, Germany), according to the manufac-
turer’s instructions. Isolation of total RNA was performed using
the MagNa Pure Compact RNA isolation kit and the MagNa Pure
Compact Instrument (Roche Applied Science, Germany). RNA
was quantified by measuring absorbance at 260 nm, and RNA
purity was determined by the ratios OD260 nm/280 nm and
OD230 nm/280 nm using the NanoDrop instrument (Nano-
Drop
H ND-1000, Wilmington, USA). The RNA integrity was
determined by electrophoresis using the Agilent 2100 Bioanalyser
(Matriks, Norway). Only samples with RNA Integrity Number
(RIN) .7.2 were used for microarray.
Microarray experimental design
mRNA was extracted for hybridization from 24 third trimester
and 16 first trimester placental samples. Three third trimester
placentas were excluded due to RIN,7.2. A total of 37
hybridisations were performed applying a direct comparison
design.
Microarray procedures
Total RNA samples were processed into digoxigenin (DIG)-
labelled cRNA using the Applied Biosystems Chemiluminescent
NanoAmp
TM RT-IVT Labeling Kit. The labelled DIG-cRNA
(10 mg per microarray) was then injected into each microarray
hybridization chamber. Following hybridization at 55uC for
16 hours, the unbound material was washed from the microarrays.
Features that retained bound DIG-labelled cRNA were visualized
using the Applied Biosystems Chemiluniescence Detection Kit.
Anti-DIG alkaline phosphatase was used to hydrolyse a chemilu-
minescence substrate to generate light at 458 nm which was than
detected by the Applied Biosystems 1700 Chemiluninescent
Microarray Analyzer. The Human Genome Survey Microarray
v.2.0 (Applied Biosystems) with 32878 probes for the interrogation
of 29098 genes was used for microarray analysis.
Data processing and statistical analysis
Microarrays were scanned and preprocessed using the R
bionconductor package (http://www.r-project.org) (scripts at-
tached in Table S5). Probes with unusual signal patterns were
flagged by the scanner and signal strength set to NA (not a
number). Arrays showing low correlation between hybridization
controls were removed. Missing intensity values were imputed
using the nearest neighbour method [33]. The resultant intensity
matrix was normalised by quantile normalization [34]. Probes
with a log2 average signal less than 8 and a variance less than 0.1
were removed as background. PCA was performed on the
remaining probes. Principal component 1 accounted for 27% of
cumulative variance, and principal component 2 for 10% of the
cumulative variance.
Gene annotations
We used Protein ANalysis THrough Evolutionary Relationships
(PANTHER) [35] which is a freely available, comprehensive
software system for relating gene sequence to specific molecular
functions, biological processes and pathways (http://www.
pantherdb.org). The expression data analysis tool, with Bonferroni
correction for multiple testing, was used in order to find signalling
pathways that might be involved in normal placental development.
Database submission of microarray data
The microarray data were prepared according to minimum
information about a microarray experiment (MIAME) recom-
mendations [36] and deposited in the Gene Expression Omnibus
(GEO) database: http://www.ncbi.nlm.nih.gov/geo/. The GEO
accession number for the platform is GSE28551, samples GSM
707051-GSM 707087.
Validation of microarray results by PCR-array and RT-PCR
We carried out quantitative RT-PCR with 200 mg total RNA
isolated from a pool of first and a separate pool of third trimester
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2 ProfilerTM Human Neurogenesis and
Neural Stem Cell PCR Array (PAHS-404, SABiosciences
Corporation, USA) according to the manufacturer’s instructions.
The plate contains primers for 84 genes related to the regulation of
key neurogenesis processes such as the cell cycle and cell
proliferation, differentiation, motility, and migration. This array
contains the growth factors and cytokines related to neural stem
cells as well as genes involved in synaptic functions, apoptosis and
cell adhesion. For detailed layout of the array see http://www.
sabiosciences.com/rt_pcr_product/HTML/PAHS-404A.html.
Actin beta (ACTB) was used as housekeeping gene. Analysis of
fold changes was done by the DDCt method using the integrated
web-based software package for the PCR Array System.
Further, the expression of selected six imprinted genes was
validated by RT-PCR. The selection was based on: a) their colour
intensity on the heat map and b) existing information in the
literature on these genes regarding their role in placental
development and disease. We chose to perform RT-PCR for
each of these genes on every individual placenta in order to find
differences in expression between the two trimesters, as well as to
explore the range of normal variations in expression within
samples in the same trimester. This method is more accurate,
although it necessitates more mRNA.
Total RNA was reverse transcribed using iScript cDNA
Synthesis Kit (Bio-Rad Laboratories, Cat# 170-8891) as described
by the manufacturer’s protocol. RT- PCR amplification was
performed with an ABI HT7900 Instrument (Applied Biosystems)
using the FastStart TaqMan Probe Master [Rox] (Roche, Cat.
No. 04673468001) with addition of Rox Reference Dye (Roche,
Cat. No. 04673549001). Thermal cycling conditions were as
follows: denaturation for 10 minutes at 95uC, then 40 cycles PCR
with denaturation for 15 seconds at 95uC; annealing and
extension for 1 minute at 60uC. Sample volume used was
20 mL. Primers and probes were constructed by using Universal
ProbeLibrary program (Roche), given in Table S6. The primers
were synthesized and purified by Thermo Fisher Scientific
(Germany) and the primers for the housekeeping genes by
Eurogentec S.S. (Belgium). The probes were obtained from
Universal ProbeLibrary Probes 1–165 (Roche). Cyclophylin A
and hypoxanthine phosphoribosyl-transferase 1 (HPRT) were used
as reference genes. Samples for each experiment were run in
duplicate and averaged for final quantification. The fold
inductions were calculated as described previously [37].
Supporting Information
Figure S1 Scatter plot of the log transformed expression
ratio of all 84 genes spotted on the RT2 ProfilerTM
Human Neurogenesis and Neural Stem Cell PCR Array.
Each spot represents a gene. The colour represents the level of
gene expression: red indicates up-regulation in the third trimester
(group 1); green indicates up-regulation in the first trimester
(control group). The black spots represent genes that had a relative
expression of #2 fold between the groups.
(JPG)
Figure S2 Two-dimensional principal component anal-
ysis of the differentially expressed placental imprinted
genes. Each spot represents a placental sample: 16 first trimester
placentas (black spots) and 21 third trimester placentas (red spots).
(JPG)
Table S1 List of all the genes, including fold-change and
p-value, which were present on the arrays.
(XLS)
Table S2 Expression of the 26 genes that had a fold
change of $2 in Neurogenesis PCR array and their
relative expression (fold-change and p-value) in micro-
arrays.
(XLS)
Table S3 Expression of selected imprinted genes (IGF2,
PHLDA2, PLAGL1, SNPRN and SLC22A18) in individual
placental samples, in the first and third trimester of
pregnancy.
(XLS)
Table S4 Expression of COX2, COX5B, CYP2D1 and
CYP2D7 in placental samples obtained from women
who smoked tobacco compared to women who did not
smoke tobacco throughout pregnancy.
(XLS)
Table S5 R bionconductor scripts used for processing
microarray data.
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tion.
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